AGP
DXCM icon

Aspire Growth Partners’s DexCom DXCM Stock Holding History

Aspire Growth Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Buy
6,725
+2,186
+48% +$146K 0.26% 73
2026
Q1 		$285K Sell
4,539
-39
-0.9% -$2.72K 0.2% 96
2025
Q4 		$304K Sell
4,578
-261
-5% -$16.9K 0.21% 92
2025
Q3 		$326K Sell
4,839
-17
-0.4% -$1.34K 0.24% 90
2025
Q2 		$424K Sell
4,856
-65
-1% -$5.09K 0.35% 71
2025
Q1 		$410K Buy
4,921
+87
+2% +$7.1K 0.36% 68
2024
Q4 		$376K Buy
+4,834
New +$358K 0.37% 69

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aspire Growth Partners's DXCM Position: Q2 2026 in Review

Aspire Growth Partners increased its DexCom (DXCM) stake by 48% in Q2 2026, buying an estimated $146K and bringing the position to 6,725 shares worth $453K. The position accounts for 0.26% of the portfolio, ranked #73.

Aspire Growth Partners first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Aspire Growth Partners held 6,725 shares of DexCom worth $453K as of Q2 2026.
  • Aspire Growth Partners bought 2,186 DexCom shares in Q2 2026, an estimated $146K.
  • DexCom made up 0.26% of Aspire Growth Partners's portfolio in Q2 2026, its #73 holding.
  • Aspire Growth Partners first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.